Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy: Comment
The Prostate · 2026-08 · 86 (11) · 1243-1244
DOI: 10.1002/pros.70064 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Prostate, online erschienen am 03.05.2026. Verfasst von Leibo Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Surgery, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, China. Die Arbeit nennt 5 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Surgery, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, China.
- Orthopaedics, Guizhou Maotai Hospital, Zunyi, China.
ORCID-Profile: Leibo Wang
Zitieren
APA
Wang, L., & Yuan, D. (2026). Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy: Comment. The Prostate, 86(11), 1243-1244. https://doi.org/10.1002/pros.70064
Vancouver
Wang L, Yuan D. Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy: Comment. The Prostate. 2026;86(11):1243-1244. doi:10.1002/pros.70064
BibTeX
@article{Wang2026,
author = {Wang, Leibo and Yuan, Duntao},
title = {Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy: Comment},
journal = {The Prostate},
year = {2026},
volume = {86},
number = {11},
pages = {1243--1244},
doi = {10.1002/pros.70064}
}
EUVIMED